Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 3

Status

Recruiting 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Pancreatic Neoplasms 7Colorectal Neoplasms 5Breast Neoplasms 5Prostatic Neoplasms 4COVID-19 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Lung Neoplasms 2Cholangiocarcinoma 2Untreated Resectable Pancreatic Adenocarcinoma 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Pancreatic Cancer Resectable 1Neoplasm, Residual 1Liver Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Klatskin Tumor 1Hypoxia 1Hematologic Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Biliary Tract Neoplasms 1

Interventions

Trastuzumab 303Paclitaxel 256Cyclophosphamide 251Docetaxel 238Capecitabine 175Letrozole 163Carboplatin 163Doxorubicin 145Fulvestrant 144Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 88Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 44Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Hydroxychloroquine × Clear all
NCT04523857 2026-05-26

ABBY

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting
44 enrolled
Breast

Breast Neoplasms

NCT04841148 2026-04-09

PALAVY

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting
96 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual

NCT03032406 2025-07-22

CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Active not recruiting
53 enrolled 12 charts
Breast

Breast Neoplasms

NCT05689359 2024-03-08

Evaluation of Hydroxychloroquine to Prevent CIPN

University of Arizona

Phase 2 Withdrawn
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT01292408 2012-01-20

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Radboud University Medical Center

Phase 2 Unknown
20 enrolled
Breast

Hypoxia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡